Envestnet Asset Management Inc. lifted its stake in shares of Express Scripts Holding Co (NASDAQ:ESRX) by 106.5% during the second quarter, HoldingsChannel.com reports. The fund owned 141,398 shares of the company’s stock after acquiring an additional 72,934 shares during the period. Envestnet Asset Management Inc.’s holdings in Express Scripts were worth $10,916,000 as of its most recent SEC filing.
Several other institutional investors also recently bought and sold shares of the company. Alps Advisors Inc. increased its holdings in Express Scripts by 128.0% in the first quarter. Alps Advisors Inc. now owns 11,781 shares of the company’s stock valued at $814,000 after buying an additional 6,615 shares during the last quarter. Westpac Banking Corp increased its holdings in Express Scripts by 5.2% in the first quarter. Westpac Banking Corp now owns 36,528 shares of the company’s stock valued at $2,523,000 after buying an additional 1,800 shares during the last quarter. Atria Investments LLC increased its holdings in Express Scripts by 22.2% in the first quarter. Atria Investments LLC now owns 15,078 shares of the company’s stock valued at $1,042,000 after buying an additional 2,738 shares during the last quarter. Boston Partners increased its holdings in Express Scripts by 12.1% in the first quarter. Boston Partners now owns 442,691 shares of the company’s stock valued at $30,581,000 after buying an additional 47,626 shares during the last quarter. Finally, Virginia Retirement Systems ET AL purchased a new position in Express Scripts in the first quarter valued at $242,000. 84.71% of the stock is currently owned by institutional investors and hedge funds.
NASDAQ ESRX opened at $89.83 on Thursday. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.71 and a quick ratio of 0.59. Express Scripts Holding Co has a 1 year low of $55.80 and a 1 year high of $90.75. The firm has a market capitalization of $49.48 billion, a price-to-earnings ratio of 10.93, a P/E/G ratio of 1.11 and a beta of 1.00.
Express Scripts (NASDAQ:ESRX) last released its quarterly earnings data on Wednesday, August 1st. The company reported $2.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.20 by $0.02. Express Scripts had a net margin of 4.65% and a return on equity of 25.49%. The company had revenue of $25.64 billion during the quarter, compared to the consensus estimate of $25.43 billion. During the same quarter in the prior year, the firm posted $1.73 earnings per share. Express Scripts’s revenue for the quarter was up 1.2% on a year-over-year basis. sell-side analysts anticipate that Express Scripts Holding Co will post 9.07 EPS for the current fiscal year.
In other Express Scripts news, insider Christine Houston sold 12,898 shares of the company’s stock in a transaction on Friday, August 10th. The shares were sold at an average price of $85.00, for a total value of $1,096,330.00. Following the completion of the transaction, the insider now owns 110,908 shares in the company, valued at $9,427,180. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.79% of the company’s stock.
Several research firms recently commented on ESRX. Robert W. Baird lowered Express Scripts from an “outperform” rating to a “neutral” rating and set a $81.00 target price on the stock. in a report on Friday, July 20th. BidaskClub raised Express Scripts from a “hold” rating to a “buy” rating in a report on Wednesday, June 13th. William Blair raised Express Scripts from a “market perform” rating to an “outperform” rating in a report on Wednesday, August 1st. Zacks Investment Research lowered Express Scripts from a “hold” rating to a “sell” rating in a report on Monday, July 23rd. Finally, Royal Bank of Canada increased their target price on Express Scripts to $94.00 and gave the company an “outperform” rating in a report on Monday, August 27th. Three research analysts have rated the stock with a sell rating, thirteen have given a hold rating and four have assigned a buy rating to the company. Express Scripts has a consensus rating of “Hold” and an average price target of $85.58.
About Express Scripts
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services.
Featured Story: Should You Consider an Index Fund?
Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Co (NASDAQ:ESRX).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.